Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines
Success against #COVID19 will likely require both vaccines & treatments. We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate—specifically designed to combat SARS-CoV-2—in non-hospitalized, low-risk adults: https://t.co/su5VtfbWPX
— AlbertBourla (@AlbertBourla) September 1, 2021
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.